EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 36 / No 4 (Avril 2020) Med Sci (Paris), 36 4 (2020) 322-326 References
Open Access
Issue
Med Sci (Paris)
Volume 36, Number 4, Avril 2020
Page(s) 322 - 326
Section Le Magazine
DOI https://doi.org/10.1051/medsci/2020051
Published online 01 May 2020
  1. Coatrieux JL, Velut J, Dillenseger JL, et al. De l’imagerie médicale à la thérapie guidée par l’image. Med Sci (Paris) 2010 ; 26 : 1103–1109. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Cordier-Bussat M, Thibert C, Sujobert P, et al. Même l’effet Warburg est oxydable : coopération métabolique et développement tumoral. Med Sci (Paris) 2018 ; 34 : 701–708. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  3. Senni N, Savall M, Cabrerizo Granados D, et al. b-catenin-activated hepatocellular carcinomas are addicted to fatty acids. Gut 2019 ; 68 : 322–334. [CrossRef] [PubMed] [Google Scholar]
  4. Yuneva MO, Fan TW, Allen TD, et al. The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab 2012 ; 15 : 157–170. [CrossRef] [PubMed] [Google Scholar]
  5. Talbot JN, Fartoux L, Balogova S, et al. Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease. J Nucl Med 2010 ; 51 : 1699–1706. [CrossRef] [PubMed] [Google Scholar]
  6. Colnot S, Decaens T, Niwa-Kawakita M, et al. Liver-targeted disruption of Apc in mice activates b-catenin signaling and leads to hepatocellular carcinomas. Proc Natl Acad Sci USA 2004 ; 101 : 17216–17221. [CrossRef] [Google Scholar]
  7. Gougelet A, Sartor C, Bachelot L, et al. Antitumour activity of an inhibitor of miR-34a in liver cancer with b-catenin-mutations. Gut 2016 ; 65 : 1024–1034. [CrossRef] [PubMed] [Google Scholar]
  8. Gougelet A, Torre C, Veber P, et al. T-cell factor 4 and b-catenin chromatin occupancies pattern zonal liver metabolism in mice. Hepatology 2014 ; 59 : 2344–2357. [CrossRef] [PubMed] [Google Scholar]
  9. Gougelet A, Sartor C, Senni N, et al. Hepatocellular carcinomas with mutational activation of b-catenin require choline and can be detected by positron emission tomography. Gastroenterology 2019 ; 157 : 807–822. [CrossRef] [PubMed] [Google Scholar]
  10. Kwee SA, Tiirikainen M, Sato MM, et al. Transcriptomics associates molecular features with 18F-fluorocholine PET/CT imaging phenotype and its potential relationship to survival in hepatocellular carcinoma. Cancer Res 2019 ; 79 : 1696–1704. [Google Scholar]
  11. Garcia Vicente AM, Perez-Beteta J, Amo-Salas M, et al. 18F-Fluorocholine PET/CT in the prediction of molecular subtypes and prognosis for gliomas. Clin Nucl Med 2019 ; 44 : e548–e558. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.